Browse
Explore conditions, clinical trials, and the organisations running them.
Never miss a new study
Get alerted when new trials match your condition
Sign up free to track the conditions you care about and get a personal digest when new trials appear.
By submitting, you agree to our Terms of use
127005 trials found · Page 1671 of 6351
-
Hidden risk: could opioid misuse be overlooked in cancer care?
Knowledge-focused PausedThe success of opioid treatment in terminally ill cancer patients set the stage for extending the same treatment principles to the treatment of all chronic pain conditions including chronic non-cancer pain and chronic pain in cancer, where survival and long-standing chronic disea…
Sponsor: Rigshospitalet, Denmark • Aim: Knowledge-focused
Last updated Aug 14, 2026 00:00 UTC
-
Viruses vs. superbugs: new hope for skin infections?
Disease control By invitation onlyThis study addresses the increasingly severe global public health challenge of antibiotic resistance, focusing on exploring phage therapy as a potential treatment strategy for multidrug-resistant bacterial skin infections. Bacteriophages, with advantages such as high specificity,…
Early phase 1 • Sponsor: First Affiliated Hospital Xi'an Jiaotong University • Aim: Disease control
Last updated Jun 27, 2026 13:01 UTC
-
Gut bacteria transplant could tame Crohn's inflammation
Disease control Recruiting nowCrohn's disease (CD) develops because of a disruption of homeostasis between the gut microbiota and the host immune system resulting in excessive inflammation in the intestinal tract. Current drug therapies for CD are directed at the immune system. The emergence of fecal microbio…
Phase 2 • Sponsor: University of Minnesota • Aim: Disease control
Last updated Sep 10, 2026 00:00 UTC
-
Can a desk workout plus pilates beat the office aches?
Symptom relief CompletedThis study evaluated whether adding Pilates exercises to a desk-based exercise program provides greater benefits for female office workers than desk-based exercises alone or no exercise intervention. The study included 42 female office workers who were randomly assigned to three …
Sponsor: Muharrem Gökhan Beydağı • Aim: Symptom relief
Last updated Aug 15, 2026 00:00 UTC
-
Can targeted therapy ease the mental health toll of stigma in LGBTQ+ people?
Symptom relief Recruiting nowLesbian, gay, bisexual, transgender, and queer+ (LGBTQ+) individuals experience a breadth of mental health disparities. Reducing these disparities is an area of key psychological research. Minority stress is theorized to be an underlying source of the disparities (Meyer, 2003). M…
Sponsor: University of Alabama at Birmingham • Aim: Symptom relief
Last updated Sep 02, 2026 00:00 UTC
-
New pill shows promise in slowing rare Cancer's growth
Disease control Recruiting nowThe study is a Phase 2 clinical trial of the drug cirtuvivint as a second-line treatment for advanced soft tissue sarcomas. The study is being conducted in Spain and is expected to enroll approximately 25 patients in total. The primary objective of this Phase 2 study is to evalua…
Phase 2 • Sponsor: Asociación Europea y Latinoamericana SELNET para la Investigación en Sarcomas • Aim: Disease control
Last updated Jun 27, 2026 12:04 UTC
-
Could a simple steroid shot before C-Section protect newborns from low blood sugar?
Disease control CompletedComparing the incidence of neonatal hypoglycemia in infants born to mothers who received antenatal corticosteroids to those who did not.
Sponsor: Assiut University • Aim: Disease control
Last updated Aug 27, 2026 00:00 UTC
-
New study targets colorectal cancer in underrepresented minorities
Disease control Recruiting nowHigh blood pressure (hypertension) is a known side effect of the treatment with fruquintinib. Current research does not provide a clear answer whether minority groups such as Black/African American and/or Hispanic/Latino with refractory metastatic colorectal cancer (mCRC) have a …
Phase 4 • Sponsor: Takeda • Aim: Disease control
Last updated Jul 09, 2026 00:00 UTC
-
Experimental cell therapy takes on stubborn brain autoimmune disorders
Disease control Recruiting nowThis study is an open-label, prospective, exploratory clinical trial that includes a dose escalation phase and a dose expansion phase, aimed at evaluating the safety, cell dynamics, and preliminary efficacy of GT719 cells in adult participants with recurrent/refractory antibody-m…
Phase 1 • Sponsor: Grit Biotechnology • Aim: Disease control
Last updated Jun 26, 2026 17:13 UTC
-
Old HIV drug repurposed to flush out hidden virus in new pilot trial
Disease control Recruiting nowAntiretroviral therapy or ART blocks HIV replication reducing plasma viral loads to undetectable levels but has no effect on persistently infected cells in the body, called the virus reservoir. These cells carry infectious HIV capable of restarting HIV replication if therapy is s…
Sponsor: University of Toronto • Aim: Disease control
Last updated Jun 27, 2026 11:02 UTC
-
New drug targets tough cancers with KRAS G12V mutation
Disease control OngoingPhase 1 study to determine the safety, tolerability, and anti-tumor activity of QTX3544 as a single agent or in combination with cetuximab.
Phase 1 • Sponsor: Quanta Therapeutics • Aim: Disease control
Last updated Jun 27, 2026 09:09 UTC
-
Exercise program aims to beat fatigue in testicular cancer survivors
Symptom relief Recruiting nowTesticular germ cell tumor (TGCT) is the most common malignancy in men between 15 and 40 years. Although TCGT survivors have a good survival prognosis, they suffer from short- and long-term sequelae such as chronic fatigue, psychological disorders, cardiovascular toxicities and s…
Sponsor: Centre Leon Berard • Aim: Symptom relief
Last updated Jun 27, 2026 12:02 UTC
-
One-shot gene therapy aims to tame rett syndrome in young girls
Disease control OngoingRett syndrome (RTT) is a serious neurodevelopmental disorder that has a significant impact on patients and their families. Patients suffer from severe social dysfunction and poor quality of life, and there is currently no effective treatment available. The MECP2 functional loss m…
Early phase 1 • Sponsor: Guangzhou Women and Children's Medical Center • Aim: Disease control
Last updated Jun 27, 2026 12:39 UTC
-
Cartoon workouts may help seniors beat fear of falling
Symptom relief CompletedImpaired mobility in older adults significantly exacerbates the risk of falls and subsequent injuries. Beyond physical sequelae, fall precipitate psychological burdens, notably the fear of falling and kinesiophobia. This study investigated the efficacy of animation-guided video e…
Sponsor: Mustafa Kemal University • Aim: Symptom relief
Last updated Jul 18, 2026 00:00 UTC
-
Could a simple eye drop stop blindness after retinal detachment?
Prevention Recruiting nowThis study has two main objectives. The first objective is to study the pharmacokinetics of topical netarsudil administration in the posterior segment of the eye, where netarsudil must exert its effect in order to prevent formation of tractional membranes. The second objective i…
Phase 1/2 • Sponsor: Massachusetts Eye and Ear Infirmary • Aim: Prevention
Last updated Jun 27, 2026 07:55 UTC
-
New study tests Mesh-Free option for bladder leak surgery
Symptom relief Recruiting nowThis prospective clinical study aims to compare the short-term effectiveness, safety, and patient-reported outcomes of two surgical techniques used for the treatment of female stress urinary incontinence (SUI): Pubo-Urethral Ligament Plication (PLP), a mesh-free native tissue rep…
Sponsor: Mehmet Incebıyik • Aim: Symptom relief
Last updated Jun 27, 2026 08:05 UTC
-
New implant aims to make dialysis easier for kidney patients
Disease control Recruiting nowVasQ is an external support implant for arteriovenous fistulas created for dialysis access. This is a postmarket surveillance, prospective, multi-center, randomized, controlled, open label trial enrolling 300 patients randomized into two study arms: * Treatment arm: End to side…
Sponsor: Laminate Medical Technologies • Aim: Disease control
Last updated Jul 16, 2026 00:00 UTC
-
New drug IMC-001 targets Hard-to-Treat cancers in small trial
Disease control Recruiting nowThe goal of this clinical trial is to determine the efficacy of IMC-001 in metastatic or locally advanced TMB-H solid tumor patients.
Phase 2 • Sponsor: ImmuneOncia Therapeutics Inc. • Aim: Disease control
Last updated Jun 27, 2026 12:08 UTC
-
Nerve transfer surgery aims to restore smiles in cancer patients
Symptom relief Recruiting nowThe goal of this research study is to measure changes in patients' quality of life after surgeries that affect the facial nerve, including nerve transfer as treatment for facial paralysis.
Sponsor: M.D. Anderson Cancer Center • Aim: Symptom relief
Last updated Jun 27, 2026 11:00 UTC
-
New implant could replace glaucoma drops after cataract surgery
Disease control Recruiting nowThis trial will evaluate the safety and IOP -lowering efficacy of administering an iDose TR (travoprost intracameral implant) in conjunction with cataract surgery compared to cataract surgery alone
Phase 4 • Sponsor: Glaukos Corporation • Aim: Disease control
Last updated Jun 27, 2026 08:12 UTC